These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2141239)

  • 1. [Use of decapeptyl (GnRH agonist) in the program of in vitro fertilization].
    Leonov BV; Lukin VA; Moskalenko NV; Lazarev AP; Pulina GA; Khil'kevich LV; Iavorovskaia KA
    Akush Ginekol (Mosk); 1990 Jan; (1):48-51. PubMed ID: 2141239
    [No Abstract]   [Full Text] [Related]  

  • 2. GnRH-agonist ovulation trigger in patients undergoing controlled ovarian hyperstimulation for IVF with ultrashort flare GnRH-agonist combined with multidose GnRH-antagonist protocol.
    Orvieto R; Nahum R; Zohav E; Liberty G; Anteby EY; Meltcer S
    Gynecol Endocrinol; 2013 Jan; 29(1):51-3. PubMed ID: 22857268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Menstrual cycle synchronization, ovarian stimulation, and in vitro fertilization in olive baboons (Papio anubis): a prospective randomized study.
    Nyachieo A; Spiessens C; Chai DC; Mwenda JM; D'Hooghe TM
    Fertil Steril; 2009 Feb; 91(2):602-10. PubMed ID: 18328482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hypophyseal suppression and subsequent cycle stimulation: experiences in an in vitro fertilization program].
    Riss P; Reinthaller A; Fischl F; Deutinger J; Müller-Tyl E; Lasnik E
    Geburtshilfe Frauenheilkd; 1989 May; 49(5):448-51. PubMed ID: 2525502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analogs of GnRH and fertilization in vitro. Value of the use of GnRH analogs in the stimulation and monitoring of ovulation for fertilization in vitro].
    Vauthier D; Lefebvre G
    J Gynecol Obstet Biol Reprod (Paris); 1987; 16(8):1075-8. PubMed ID: 2967320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovulation induction for in-vitro-fertilization and embryo transfer applying decapeptyl (DTRP-6 LH/RH) in combination with HMG or FSH.
    Mettler L; Argiriou C; Abd-el Maeboud K; Steinmüller H; Semm K
    Exp Clin Endocrinol; 1988 Mar; 92(3):245-51. PubMed ID: 2978123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between gonadotropin releasing hormone agonist dosage and in vitro fertilization outcome.
    Lorusso F; Depalo R; Selvaggi L
    Gynecol Endocrinol; 2004 Feb; 18(2):69-73. PubMed ID: 15195497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrashort gonadotropin-releasing hormone agonist combined with flexible multidose gonadotropin-releasing hormone antagonist for poor responders in in vitro fertilization/embryo transfer programs.
    Orvieto R; Kruchkovich J; Rabinson J; Zohav E; Anteby EY; Meltcer S
    Fertil Steril; 2008 Jul; 90(1):228-30. PubMed ID: 17681292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormonal stimulation for in vitro fertilization: a comparison of fertilization rates and cytogenetic findings in unfertilized oocytes.
    De Sutter P; Dhont M; Vandekerckhove D
    J Assist Reprod Genet; 1992 Jun; 9(3):254-8. PubMed ID: 1525457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GnRH agonist increases pregnancy potential of retrieved oocytes given adequate preincubation before insemination: a comparative study.
    Feldberg D; Goldman GA; Dicker D; Ashkenazi J; Shelef M; Goldman JA
    Eur J Obstet Gynecol Reprod Biol; 1991 Apr; 39(2):111-6. PubMed ID: 1828775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Systematic inhibition of the luteinizing hormone with a gonadoliberin analog, triptorelin, during ovarian stimulation for fertilization in vitro. Choice of protocol].
    Fenichel P; Grimaldi M; Hieronimus S; Olivero JF; Donzeau A; Benoit B; Fiorentini M; Tran DK; Harter M; Gillet JY
    Presse Med; 1988 Apr; 17(15):719-22. PubMed ID: 2968548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GnRH agonists and in vitro fertilization.
    Barlow DH
    J Reprod Med; 1998 Mar; 43(3 Suppl):245-51. PubMed ID: 9564657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early luteal phase endocrine profile is affected by the mode of triggering final oocyte maturation and the luteal phase support used in recombinant follicle-stimulating hormone-gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
    Fatemi HM; Polyzos NP; van Vaerenbergh I; Bourgain C; Blockeel C; Alsbjerg B; Papanikolaou EG; Humaidan P
    Fertil Steril; 2013 Sep; 100(3):742-7. PubMed ID: 23806846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study.
    Bodri D; Guillén JJ; Galindo A; Mataró D; Pujol A; Coll O
    Fertil Steril; 2009 Feb; 91(2):365-71. PubMed ID: 18367175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of different stimulation treatments on oocyte characteristics and in-vitro fertilizing ability.
    Testart J; Belaisch-Allart J; Forman R; Gazengel A; Strubb N; Hazout A; Frydman R
    Hum Reprod; 1989 Feb; 4(2):192-7. PubMed ID: 2521865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Simulation of ovulation using two types of LH-RH agonists].
    Frydman R; Belaisch-Allart J; Fernandez H; Baton C; Glissant A; Hazout A
    J Steroid Biochem; 1989 Oct; 33(4B):827-9. PubMed ID: 2532271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypophyseal blockage by a gonadorelin analogue, D-Trp6-LHRH retard, to improve induction of ovulation].
    Fenichel P; Grimaldi M; Greck T; Benoit B; Fiorentini M; Tran DK; Gillet JY; Harter M
    Presse Med; 1986 Dec; 15(43):2167. PubMed ID: 2954069
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison between a GnRH antagonist and a GnRH agonist flare-up protocol in oocyte donors: a randomized clinical trial.
    Bodri D; Vernaeve V; Guillén JJ; Vidal R; Figueras F; Coll O
    Hum Reprod; 2006 Sep; 21(9):2246-51. PubMed ID: 16704995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian stimulation for in vitro fertilization and GIFT combining administration of gonadotropins and blockade of the pituitary with D-Trp6-LH-RH.
    Zorn JR; Barata M; Brami C; Epelboin S; Nathan C; Papageorgiou G; Quantin P; Rolet F; Savale M; Boyer P
    Eur J Obstet Gynecol Reprod Biol; 1988 Jun; 28(2):116-20. PubMed ID: 2969836
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro fertilization cycle outcome after coasting in gonadotropin-releasing hormone (GnRH) agonist versus GnRH antagonist protocols.
    Farhi J; Ben-Haroush A; Lande Y; Sapir O; Pinkas H; Fisch B
    Fertil Steril; 2009 Feb; 91(2):377-82. PubMed ID: 18321490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.